ADHERENCE TO NEBULISED THERAPIES IN PEOPLE WITH CYSTIC FIBROSIS STARTING ELEXACAFTOR/TEZACAFTOR/IVACAFTOR (KAFTRIO)

被引：1
|
作者：
Howell, I. B. [1 ]
Tugwell, A. [1 ]
Bhaskaran, D. [1 ]
Bell, N. J. [1 ]
机构：
[1] Bristol Adult Cyst Fibrosis Ctr, Bristol, Avon, England
来源：
THORAX | 2021年 / 76卷
关键词：
D O I：
10.1136/thorax-2021-BTSabstracts.65
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
S59
引用
收藏
页码：A40 / A40
页数：1
相关论文
共 50 条
  • [1] The impact of elexacaftor/tezacaftor/ivacaftor on adherence to maintenance therapies in cystic fibrosis
    Johnson, Ellie
    Land, Rachel
    Reid, David
    RESPIROLOGY, 2024, 29 : 7 - 7
  • [2] Research letter: The impact of elexacaftor/tezacaftor/ivacaftor on adherence to nebulized maintenance therapies in people with cystic fibrosis
    Song, Jia Tong
    Desai, Sameer
    Franciosi, Alessandro N.
    Dagenais, Renee V. E.
    Quon, Bradley S.
    JOURNAL OF CYSTIC FIBROSIS, 2022, 21 (06) : 1080 - 1081
  • [3] Delayed hepatic necrosis in a cystic fibrosis patient taking Elexacaftor/Tezacaftor/Ivacaftor (Kaftrio)
    Salehi, Mahan
    Iqbal, Mubashar
    Dube, Asha
    AlJoudeh, Amer
    Edenborough, Frank
    RESPIRATORY MEDICINE CASE REPORTS, 2021, 34
  • [4] Clinical Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis
    Nichols, David P.
    Paynter, Alex C.
    Heltshe, Sonya L.
    Donaldson, Scott H.
    Frederick, Carla A.
    Freedman, Steven D.
    Gelfond, Daniel
    Hoffman, Lucas R.
    Kelly, Andrea
    Narkewicz, Michael R.
    Pittman, Jessica E.
    Ratjen, Felix
    Rosenfeld, Margaret
    Sagel, Scott D.
    Schwarzenberg, Sarah Jane
    Singh, Pradeep K.
    Solomon, George M.
    Stalvey, Michael S.
    Clancy, John P.
    Kirby, Shannon
    Van Dalfsen, Jill M.
    Kloster, Margaret H.
    Rowe, Steven M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205 (05) : 529 - 539
  • [5] Elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis and rare mutations
    Fainardi, Valentina
    Cresta, Federico
    Sorio, Claudio
    Melotti, Paola
    Pesce, Emanuela
    Deolmi, Michela
    Longo, Francesco
    Karina, Kleinfelder
    Esposito, Susanna
    Pisi, Giovanna
    PEDIATRIC PULMONOLOGY, 2024, 59 (12) : 3383 - 3390
  • [6] Heterogeneity in response to Elexacaftor/Tezacaftor/Ivacaftor in people with cystic fibrosis
    Alicandro, Gianfranco
    Gramegna, Andrea
    Bellino, Federica
    Sciarrabba, Sathya Calogero
    Lanfranchi, Chiara
    Contarini, Martina
    Retucci, Mariangela
    Blasi, Francesco
    JOURNAL OF CYSTIC FIBROSIS, 2024, 23 (06) : 1072 - 1079
  • [7] Elexacaftor/Tezacaftor/Ivacaftor (Trikafta) for Cystic Fibrosis
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2020, 62 (1589): : 5 - 7
  • [8] Cystic Fibrosis: Triple Therapy with Elexacaftor, Tezacaftor and Ivacaftor
    Lorenz, Judith
    PNEUMOLOGIE, 2022, 76 (03): : 153 - 153
  • [9] Tolerance of elexacaftor/tezacaftor/ivacaftor in Australians with cystic fibrosis
    Ruseckaite, Rasa
    Wark, Peter
    Pourghaderi, Ahmadreza
    Caruso, Marisa
    Ahern, Susannah
    RESPIROLOGY, 2024, 29 : 8 - 8
  • [10] Impact of elexacaftor/tezacaftor/ivacaftor on bacterial cultures from people with cystic fibrosis
    Beck, Michael R.
    Hornick, Douglas B.
    Pena, Tahuanty A.
    Singh, Sachinkumar B.
    Wright, Brittany A.
    PEDIATRIC PULMONOLOGY, 2023, 58 (05) : 1569 - 1573
12345